|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Virginia
|
52-1549373
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
incorporation or organization)
|
Identification No.)
|
|
|
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia
|
23060-9245
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
(804) 217-5800
(Registrant’s telephone number, including area code)
|
Large accelerated filer
|
o
|
Accelerated filer
|
x
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
Emerging growth company
|
o
|
|
|
|
Page
|
|
|||
|
|
|
|
|
|
||
|
|
|
|
|
|
Consolidated Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017
|
|
|
|
|
|
|
|
Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2018 (unaudited) and June 30, 2017 (unaudited)
|
|
|
|
|
|
|
|
Consolidated Statement of Shareholders' Equity for the six months ended June 30, 2018 (unaudited)
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows for the six months ended June 30, 2018 (unaudited) and June 30, 2017 (unaudited)
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
ASSETS
|
(unaudited)
|
|
|
||||
Investments in securities, at fair value:
|
|
|
|
||||
Mortgage-backed securities (including pledged of $2,645,293 and $2,640,884 respectively)
|
$
|
2,759,894
|
|
|
$
|
3,026,989
|
|
U.S. Treasuries (including pledged of $57,923 and $124,215, respectively)
|
57,923
|
|
|
146,530
|
|
||
|
|
|
|
||||
Mortgage loans held for investment, net
|
13,628
|
|
|
15,738
|
|
||
Cash and cash equivalents
|
165,126
|
|
|
40,867
|
|
||
Restricted cash
|
52,832
|
|
|
46,333
|
|
||
Derivative assets
|
7,642
|
|
|
2,940
|
|
||
Receivable for securities sold
|
277
|
|
|
—
|
|
||
Principal receivable on investments
|
45
|
|
|
165
|
|
||
Accrued interest receivable
|
19,326
|
|
|
19,819
|
|
||
Other assets, net
|
6,084
|
|
|
6,397
|
|
||
Total assets
|
$
|
3,082,777
|
|
|
$
|
3,305,778
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
||
Liabilities:
|
|
|
|
|
|
||
Repurchase agreements
|
$
|
2,514,984
|
|
|
$
|
2,565,902
|
|
Payable for unsettled securities
|
529
|
|
|
156,899
|
|
||
Non-recourse collateralized financing
|
4,393
|
|
|
5,520
|
|
||
Derivative liabilities
|
—
|
|
|
269
|
|
||
Accrued interest payable
|
5,469
|
|
|
3,734
|
|
||
Accrued dividends payable
|
12,727
|
|
|
12,526
|
|
||
Other liabilities
|
2,441
|
|
|
3,870
|
|
||
Total liabilities
|
2,540,543
|
|
|
2,748,720
|
|
||
|
|
|
|
|
|||
Shareholders’ equity:
|
|
|
|
|
|
||
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 5,908,999 and 5,888,680 shares issued and outstanding, respectively ($147,725 and $147,217 aggregate liquidation preference, respectively)
|
$
|
141,788
|
|
|
$
|
141,294
|
|
Common stock, par value $.01 per share, 200,000,000 shares authorized;
56,906,200 and 55,831,549 shares issued and outstanding, respectively
|
569
|
|
|
558
|
|
||
Additional paid-in capital
|
782,011
|
|
|
775,873
|
|
||
Accumulated other comprehensive loss
|
(63,919
|
)
|
|
(8,697
|
)
|
||
Accumulated deficit
|
(318,215
|
)
|
|
(351,970
|
)
|
||
Total shareholders’ equity
|
542,234
|
|
|
557,058
|
|
||
Total liabilities and shareholders’ equity
|
$
|
3,082,777
|
|
|
$
|
3,305,778
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Interest income
|
$
|
25,922
|
|
|
$
|
24,856
|
|
|
$
|
51,112
|
|
|
$
|
47,275
|
|
Interest expense
|
14,175
|
|
|
8,714
|
|
|
25,770
|
|
|
16,233
|
|
||||
Net interest income
|
11,747
|
|
|
16,142
|
|
|
25,342
|
|
|
31,042
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Gain (loss) on derivative instruments, net
|
20,667
|
|
|
(15,802
|
)
|
|
59,021
|
|
|
(15,627
|
)
|
||||
Loss on sale of investments, net
|
(12,444
|
)
|
|
(3,709
|
)
|
|
(16,219
|
)
|
|
(5,417
|
)
|
||||
Fair value adjustments, net
|
27
|
|
|
30
|
|
|
56
|
|
|
40
|
|
||||
Other (expense) income, net
|
(339
|
)
|
|
4
|
|
|
(592
|
)
|
|
(42
|
)
|
||||
General and administrative expenses:
|
|
|
|
|
|
|
|
||||||||
Compensation and benefits
|
(1,751
|
)
|
|
(2,041
|
)
|
|
(3,713
|
)
|
|
(4,286
|
)
|
||||
Other general and administrative
|
(2,255
|
)
|
|
(2,056
|
)
|
|
(3,936
|
)
|
|
(4,091
|
)
|
||||
Net income (loss)
|
15,652
|
|
|
(7,432
|
)
|
|
59,959
|
|
|
1,619
|
|
||||
Preferred stock dividends
|
(2,942
|
)
|
|
(2,641
|
)
|
|
(5,882
|
)
|
|
(5,077
|
)
|
||||
Net income (loss) to common shareholders
|
$
|
12,710
|
|
|
$
|
(10,073
|
)
|
|
$
|
54,077
|
|
|
$
|
(3,458
|
)
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|||||||
Unrealized (loss) gain on available-for-sale investments, net
|
$
|
(22,156
|
)
|
|
$
|
8,739
|
|
|
$
|
(71,345
|
)
|
|
$
|
27,107
|
|
Reclassification adjustment for loss on sale of investments, net
|
12,444
|
|
|
3,709
|
|
|
16,219
|
|
|
5,417
|
|
||||
Reclassification adjustment for de-designated cash flow hedges
|
(48
|
)
|
|
(73
|
)
|
|
(96
|
)
|
|
(172
|
)
|
||||
Total other comprehensive (loss) income
|
(9,760
|
)
|
|
12,375
|
|
|
(55,222
|
)
|
|
32,352
|
|
||||
Comprehensive income (loss) to common shareholders
|
$
|
2,950
|
|
|
$
|
2,302
|
|
|
$
|
(1,145
|
)
|
|
$
|
28,894
|
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) per common share-basic and diluted
|
$
|
0.23
|
|
|
$
|
(0.20
|
)
|
|
$
|
0.96
|
|
|
$
|
(0.07
|
)
|
Weighted average common shares-basic and diluted
|
56,295
|
|
|
49,218
|
|
|
56,084
|
|
|
49,197
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Accumulated
Deficit
|
|
Total Shareholders’ Equity
|
||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||
Balance as of
December 31, 2017
|
5,888,680
|
|
$
|
141,294
|
|
|
55,831,549
|
|
$
|
558
|
|
|
$
|
775,873
|
|
|
$
|
(8,697
|
)
|
|
$
|
(351,970
|
)
|
|
$
|
557,058
|
|
Stock issuance
|
20,319
|
|
494
|
|
|
918,629
|
|
10
|
|
|
5,904
|
|
|
—
|
|
|
—
|
|
|
6,408
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
213,157
|
|
2
|
|
|
627
|
|
|
—
|
|
|
—
|
|
|
629
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(57,135
|
)
|
(1
|
)
|
|
(363
|
)
|
|
—
|
|
|
—
|
|
|
(364
|
)
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(30
|
)
|
|
—
|
|
|
—
|
|
|
(30
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
59,959
|
|
|
59,959
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,882
|
)
|
|
(5,882
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(20,322
|
)
|
|
(20,322
|
)
|
||||||
Other comprehensive loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(55,222
|
)
|
|
—
|
|
|
(55,222
|
)
|
||||||
Balance as of
June 30, 2018
|
5,908,999
|
|
$
|
141,788
|
|
|
56,906,200
|
|
$
|
569
|
|
|
$
|
782,011
|
|
|
$
|
(63,919
|
)
|
|
$
|
(318,215
|
)
|
|
$
|
542,234
|
|
|
Six Months Ended
|
||||||
|
June 30,
|
||||||
|
2018
|
|
2017
|
||||
Operating activities:
|
|
|
|
||||
Net income
|
$
|
59,959
|
|
|
$
|
1,619
|
|
Adjustments to reconcile net income to cash provided by operating activities:
|
|
|
|
|
|
||
Decrease in accrued interest receivable
|
493
|
|
|
1,101
|
|
||
Increase (decrease) in accrued interest payable
|
1,735
|
|
|
(1,633
|
)
|
||
(Gain) loss on derivative instruments, net
|
(59,021
|
)
|
|
15,627
|
|
||
Loss on sale of investments, net
|
16,219
|
|
|
5,417
|
|
||
Fair value adjustments, net
|
(56
|
)
|
|
(40
|
)
|
||
Amortization of investment premiums, net
|
74,136
|
|
|
81,188
|
|
||
Other amortization and depreciation, net
|
625
|
|
|
682
|
|
||
Stock-based compensation expense
|
629
|
|
|
1,179
|
|
||
Change in other assets and liabilities, net
|
(1,744
|
)
|
|
(2,120
|
)
|
||
Net cash and cash equivalents provided by operating activities
|
92,975
|
|
|
103,020
|
|
||
Investing activities:
|
|
|
|
|
|
||
Purchase of investments
|
(567,704
|
)
|
|
(282,943
|
)
|
||
Principal payments received on investments
|
95,452
|
|
|
183,636
|
|
||
Proceeds from sales of investments
|
525,973
|
|
|
399,483
|
|
||
Principal payments received on mortgage loans held for investment, net
|
2,101
|
|
|
1,876
|
|
||
Net receipts on derivatives, including terminations
|
54,050
|
|
|
7,405
|
|
||
Other investing activities
|
(68
|
)
|
|
(212
|
)
|
||
Net cash and cash equivalents provided by investing activities
|
109,804
|
|
|
309,245
|
|
||
Financing activities:
|
|
|
|
|
|
||
Borrowings under repurchase agreements
|
54,577,482
|
|
|
39,007,126
|
|
||
Repayments of repurchase agreement borrowings
|
(54,628,400
|
)
|
|
(39,365,319
|
)
|
||
Principal payments on non-recourse collateralized financing
|
(1,144
|
)
|
|
(557
|
)
|
||
Proceeds from issuance of preferred stock
|
494
|
|
|
18,212
|
|
||
Proceeds from issuance of common stock
|
5,914
|
|
|
139
|
|
||
Cash paid for stock issuance costs
|
—
|
|
|
(52
|
)
|
||
Payments related to tax withholding for stock-based compensation
|
(364
|
)
|
|
(521
|
)
|
||
Dividends paid
|
(26,003
|
)
|
|
(23,942
|
)
|
||
Net cash and cash equivalents used in financing activities
|
(72,021
|
)
|
|
(364,914
|
)
|
||
|
|
|
|
||||
Net increase in cash, cash equivalents, and restricted cash
|
130,758
|
|
|
47,351
|
|
||
Cash, cash equivalents, and restricted cash at beginning of period
|
87,200
|
|
|
98,889
|
|
||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
217,958
|
|
|
$
|
146,240
|
|
Supplemental Disclosure of Cash Activity:
|
|
|
|
|
|
||
Cash paid for interest
|
$
|
24,114
|
|
|
$
|
18,029
|
|
|
|
June 30, 2018
|
||
Cash and cash equivalents
|
|
$
|
165,126
|
|
Restricted cash
|
|
52,832
|
|
|
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows
|
|
$
|
217,958
|
|
|
June 30, 2018
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency
|
$
|
1,161,063
|
|
|
$
|
41,778
|
|
|
$
|
1,202,841
|
|
|
$
|
886
|
|
|
$
|
(29,114
|
)
|
|
$
|
1,174,613
|
|
|
3.79
|
%
|
Non-Agency
|
952
|
|
|
—
|
|
|
952
|
|
|
28
|
|
|
(20
|
)
|
|
960
|
|
|
6.75
|
%
|
||||||
|
1,162,015
|
|
|
41,778
|
|
|
1,203,793
|
|
|
914
|
|
|
(29,134
|
)
|
|
1,175,573
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
998,502
|
|
|
10,385
|
|
|
1,008,887
|
|
|
563
|
|
|
(43,926
|
)
|
|
965,524
|
|
|
3.05
|
%
|
||||||
Non-Agency
|
7,322
|
|
|
(3,384
|
)
|
|
3,938
|
|
|
1,675
|
|
|
—
|
|
|
5,613
|
|
|
10.83
|
%
|
||||||
|
1,005,824
|
|
|
7,001
|
|
|
1,012,825
|
|
|
2,238
|
|
|
(43,926
|
)
|
|
971,137
|
|
|
|
|||||||
CMBS IO
(2)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
338,476
|
|
|
338,476
|
|
|
3,611
|
|
|
(594
|
)
|
|
341,493
|
|
|
0.61
|
%
|
||||||
Non-Agency
|
—
|
|
|
268,976
|
|
|
268,976
|
|
|
3,328
|
|
|
(613
|
)
|
|
271,691
|
|
|
0.60
|
%
|
||||||
|
—
|
|
|
607,452
|
|
|
607,452
|
|
|
6,939
|
|
|
(1,207
|
)
|
|
613,184
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasuries:
|
59,000
|
|
|
(1,027
|
)
|
|
57,973
|
|
|
—
|
|
|
(50
|
)
|
|
57,923
|
|
|
2.50
|
%
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total AFS securities:
|
$
|
2,226,839
|
|
|
$
|
655,204
|
|
|
$
|
2,882,043
|
|
|
$
|
10,091
|
|
|
$
|
(74,317
|
)
|
|
$
|
2,817,817
|
|
|
|
(1)
|
The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
The notional balance for Agency CMBS IO and non-Agency CMBS IO was
$14,084,428
and
$10,517,357
respectively, as of
June 30, 2018
.
|
|
December 31, 2017
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC
(1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Agency
(2)
|
$
|
1,146,553
|
|
|
$
|
46,021
|
|
|
$
|
1,192,574
|
|
|
$
|
1,626
|
|
|
$
|
(9,939
|
)
|
|
$
|
1,184,261
|
|
|
3.56
|
%
|
Non-Agency
|
1,070
|
|
|
—
|
|
|
1,070
|
|
|
41
|
|
|
(20
|
)
|
|
1,091
|
|
|
6.75
|
%
|
||||||
|
1,147,623
|
|
|
46,021
|
|
|
1,193,644
|
|
|
1,667
|
|
|
(9,959
|
)
|
|
1,185,352
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
1,123,967
|
|
|
10,442
|
|
|
1,134,409
|
|
|
3,514
|
|
|
(13,572
|
)
|
|
1,124,351
|
|
|
3.03
|
%
|
||||||
Non-Agency
|
26,501
|
|
|
(4,035
|
)
|
|
22,466
|
|
|
2,298
|
|
|
—
|
|
|
24,764
|
|
|
5.47
|
%
|
||||||
|
1,150,468
|
|
|
6,407
|
|
|
1,156,875
|
|
|
5,812
|
|
|
(13,572
|
)
|
|
1,149,115
|
|
|
|
|||||||
CMBS IO
(3)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
375,361
|
|
|
375,361
|
|
|
5,238
|
|
|
(293
|
)
|
|
380,306
|
|
|
0.62
|
%
|
||||||
Non-Agency
|
—
|
|
|
308,472
|
|
|
308,472
|
|
|
4,468
|
|
|
(724
|
)
|
|
312,216
|
|
|
0.61
|
%
|
||||||
|
—
|
|
|
683,833
|
|
|
683,833
|
|
|
9,706
|
|
|
(1,017
|
)
|
|
692,522
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
U.S. Treasuries:
|
148,400
|
|
|
(133
|
)
|
|
148,267
|
|
|
—
|
|
|
(1,737
|
)
|
|
146,530
|
|
|
2.13
|
%
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Total AFS securities:
|
$
|
2,446,491
|
|
|
$
|
736,128
|
|
|
$
|
3,182,619
|
|
|
$
|
17,185
|
|
|
$
|
(26,285
|
)
|
|
$
|
3,173,519
|
|
|
|
|
(1)
|
The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
Includes purchased securities pending settlement.
|
(3)
|
The notional balance for the Agency CMBS IO and non-Agency CMBS IO was
$14,196,122
and
$11,006,463
, respectively, as of
December 31, 2017
.
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
Less than 1 year
|
|
$
|
37,630
|
|
|
$
|
37,723
|
|
|
$
|
4,480
|
|
|
$
|
4,542
|
|
>
1 and <5 years
|
|
180,549
|
|
|
182,064
|
|
|
208,046
|
|
|
210,727
|
|
||||
>
5 and <10 years
|
|
1,074,637
|
|
|
1,037,864
|
|
|
1,334,795
|
|
|
1,326,178
|
|
||||
>
10 years
|
|
1,589,227
|
|
|
1,560,166
|
|
|
1,635,298
|
|
|
1,632,072
|
|
||||
|
|
$
|
2,882,043
|
|
|
$
|
2,817,817
|
|
|
$
|
3,182,619
|
|
|
$
|
3,173,519
|
|
|
Three Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||
Agency RMBS
|
$
|
217,837
|
|
|
$
|
(7,785
|
)
|
|
$
|
265,893
|
|
|
$
|
(5,524
|
)
|
Agency CMBS
|
—
|
|
|
—
|
|
|
24,305
|
|
|
574
|
|
||||
Non-Agency CMBS
|
—
|
|
|
—
|
|
|
35,705
|
|
|
1,199
|
|
||||
Non-Agency RMBS
|
—
|
|
|
—
|
|
|
16,407
|
|
|
42
|
|
||||
Non-Agency CMBS IO
|
8,695
|
|
|
51
|
|
|
—
|
|
|
—
|
|
||||
U.S. Treasuries
|
144,461
|
|
|
(4,710
|
)
|
|
—
|
|
|
—
|
|
||||
|
$
|
370,993
|
|
|
$
|
(12,444
|
)
|
|
$
|
342,310
|
|
|
$
|
(3,709
|
)
|
|
|
|
|
|
|
|
|
||||||||
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||
Agency RMBS
|
$
|
217,837
|
|
|
$
|
(7,785
|
)
|
|
$
|
323,057
|
|
|
$
|
(7,232
|
)
|
Agency CMBS
|
108,758
|
|
|
(2,052
|
)
|
|
24,305
|
|
|
574
|
|
||||
Non-Agency CMBS
|
—
|
|
|
—
|
|
|
35,705
|
|
|
1,199
|
|
||||
Non-Agency RMBS
|
—
|
|
|
—
|
|
|
16,407
|
|
|
42
|
|
||||
Non-Agency CMBS IO
|
8,695
|
|
|
51
|
|
|
—
|
|
|
—
|
|
||||
U.S. Treasuries
|
190,960
|
|
|
(6,433
|
)
|
|
—
|
|
|
—
|
|
||||
|
$
|
526,250
|
|
|
$
|
(16,219
|
)
|
|
$
|
399,474
|
|
|
$
|
(5,417
|
)
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
||||||||
Continuous unrealized loss position for less than 12 months:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
1,907,732
|
|
|
$
|
(54,067
|
)
|
|
113
|
|
$
|
1,293,798
|
|
|
$
|
(9,769
|
)
|
|
71
|
Non-Agency MBS
|
59,125
|
|
|
(377
|
)
|
|
17
|
|
51,406
|
|
|
(421
|
)
|
|
11
|
||||
U.S. Treasuries
|
57,923
|
|
|
(50
|
)
|
|
1
|
|
146,530
|
|
|
(1,737
|
)
|
|
1
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Continuous unrealized loss position for 12 months or longer:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
257,394
|
|
|
$
|
(19,567
|
)
|
|
16
|
|
$
|
423,698
|
|
|
$
|
(14,035
|
)
|
|
30
|
Non-Agency MBS
|
13,105
|
|
|
(256
|
)
|
|
10
|
|
20,414
|
|
|
(323
|
)
|
|
12
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||||
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
||||||||||
Agency RMBS
|
|
$
|
1,076,707
|
|
|
2.08
|
%
|
|
$
|
1,133,919
|
|
|
$
|
836,281
|
|
|
1.47
|
%
|
|
$
|
867,120
|
|
Agency CMBS
|
|
849,693
|
|
|
2.05
|
%
|
|
905,690
|
|
|
1,003,146
|
|
|
1.44
|
%
|
|
1,071,904
|
|
||||
Agency CMBS IO
|
|
301,559
|
|
|
2.53
|
%
|
|
334,539
|
|
|
324,163
|
|
|
2.17
|
%
|
|
372,077
|
|
||||
Non-Agency CMBS IO
|
|
229,638
|
|
|
2.99
|
%
|
|
271,145
|
|
|
263,694
|
|
|
2.43
|
%
|
|
311,571
|
|
||||
Non-Agency CMBS
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
15,508
|
|
|
2.47
|
%
|
|
18,212
|
|
||||
U.S. Treasuries
|
|
57,387
|
|
|
2.25
|
%
|
|
57,923
|
|
|
123,110
|
|
|
1.85
|
%
|
|
124,215
|
|
||||
Total repurchase agreements
|
|
$
|
2,514,984
|
|
|
2.21
|
%
|
|
$
|
2,703,216
|
|
|
$
|
2,565,902
|
|
|
1.67
|
%
|
|
$
|
2,765,099
|
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||
Remaining Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
||||||
Less than 30 days
|
|
$
|
1,859,964
|
|
|
49
|
|
|
$
|
2,240,791
|
|
|
49
|
|
30 to 90 days
|
|
635,668
|
|
|
92
|
|
|
274,231
|
|
|
90
|
|
||
91 to 180 days
|
|
19,352
|
|
|
178
|
|
|
50,880
|
|
|
121
|
|
||
Total
|
|
$
|
2,514,984
|
|
|
61
|
|
|
$
|
2,565,902
|
|
|
54
|
|
|
|
June 30, 2018
|
|||||||||
Counterparty Name
|
|
Balance
|
|
Weighted Average Rate
|
|
Equity at Risk
|
|||||
Wells Fargo Bank, N. A. and affiliates
|
|
$
|
317,419
|
|
|
2.79
|
%
|
|
$
|
50,492
|
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
June 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
2,514,984
|
|
|
$
|
—
|
|
|
$
|
2,514,984
|
|
|
$
|
(2,514,984
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
2,565,902
|
|
|
$
|
—
|
|
|
$
|
2,565,902
|
|
|
$
|
(2,565,902
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.
|
Type of Derivative Instrument
|
|
Balance Sheet Location
|
|
Purpose
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
Interest rate swaps
|
|
Derivative assets
|
|
Economic hedging
|
|
$
|
985
|
|
|
$
|
791
|
|
Eurodollar futures
|
|
Derivative assets
|
|
Economic hedging
|
|
967
|
|
|
666
|
|
||
TBA securities
|
|
Derivative assets
|
|
Trading
|
|
2,034
|
|
|
1,483
|
|
||
Options on U.S. Treasury futures
|
|
Derivative assets
|
|
Trading
|
|
3,656
|
|
|
—
|
|
||
|
|
|
|
|
|
$
|
7,642
|
|
|
$
|
2,940
|
|
|
|
|
|
|
|
|
|
|
||||
TBA securities
|
|
Derivative liabilities
|
|
Economic hedging
|
|
$
|
—
|
|
|
$
|
(269
|
)
|
|
|
June 30, 2018
|
|||||||||||
|
|
|
|
Weighted-Average:
|
|
|
|||||||
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
(3)
|
|||||
<
3 years
|
|
$
|
1,220,000
|
|
|
1.63
|
%
|
|
1.3
|
|
$
|
985
|
|
>3 and
<
6 years
|
|
1,310,000
|
|
|
2.01
|
%
|
|
4.2
|
|
—
|
|
||
>6 and
<
10 years
|
|
1,100,000
|
|
|
2.56
|
%
|
|
8.0
|
|
—
|
|
||
>10 years
|
|
220,000
|
|
|
2.81
|
%
|
|
22.4
|
|
—
|
|
||
Total
|
|
$
|
3,850,000
|
|
|
2.07
|
%
|
|
5.2
|
|
$
|
985
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
December 31, 2017
|
|||||||||||
|
|
|
|
Weighted-Average:
|
|
|
|||||||
Years to Maturity:
|
|
Net Notional Amount
(1)
|
|
Pay Rate
(2)
|
|
Life Remaining (in Years)
|
|
Fair Value
(3)
|
|||||
<
3 years
|
|
$
|
3,320,000
|
|
|
1.35
|
%
|
|
0.7
|
|
$
|
791
|
|
>3 and
<
6 years
|
|
1,210,000
|
|
|
2.00
|
%
|
|
4.6
|
|
—
|
|
||
>6 and
<
10 years
|
|
1,025,000
|
|
|
2.49
|
%
|
|
8.0
|
|
—
|
|
||
>10 years
|
|
120,000
|
|
|
2.75
|
%
|
|
17.3
|
|
—
|
|
||
Total
|
|
$
|
5,675,000
|
|
|
1.71
|
%
|
|
3.1
|
|
$
|
791
|
|
(1)
|
The net notional amounts included in the tables above represent pay-fixed interest rate swaps, net of receive-fixed interest rate swaps and include
$1,575,000
and
$2,525,000
of pay-fixed forward starting interest rate swaps as of
June 30, 2018
and
December 31, 2017
, respectively.
|
(2)
|
Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was
1.85%
and
1.36%
as of
June 30, 2018
and
December 31, 2017
, respectively.
|
(3)
|
The majority of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to
Note 1
for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral.
|
|
|
June 30, 2018
|
||||||||||||||
TBA Securities:
|
|
Notional Amount
(1)
|
|
Implied Cost Basis
(2)
|
|
Implied Market Value
(3)
|
|
Net Carrying Value
(4)
|
||||||||
Dollar roll positions
|
|
$
|
765,000
|
|
|
$
|
782,408
|
|
|
$
|
784,442
|
|
|
$
|
2,034
|
|
Economic hedges
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Notional Amount
(1)
|
|
Implied Cost Basis
(2)
|
|
Implied Market Value
(3)
|
|
Net Carrying Value
(4)
|
||||||||
Dollar roll positions
|
|
$
|
795,000
|
|
|
$
|
829,425
|
|
|
$
|
830,908
|
|
|
$
|
1,483
|
|
Economic hedges
|
|
$
|
150,000
|
|
|
$
|
(153,797
|
)
|
|
$
|
(154,066
|
)
|
|
$
|
(269
|
)
|
(1)
|
Notional amount represents the par value (or principal balance) of the underlying Agency MBS as if settled as of the end of the period.
|
(2)
|
Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of end of the period.
|
(3)
|
Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the end of the period.
|
(4)
|
Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the end of the period.
|
Type of Derivative Instrument
|
|
Notional Amount as of December 31, 2017
|
|
Additions
|
|
Settlements,
Terminations,
or Pair-Offs
|
|
Notional Amount as of June 30, 2018
|
||||||||
Receive-fixed interest rate swaps
|
|
$
|
100,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
100,000
|
|
Pay-fixed interest rate swaps
|
|
5,775,000
|
|
|
575,000
|
|
|
(2,400,000
|
)
|
|
3,950,000
|
|
||||
Eurodollar futures
(1)
|
|
1,950,000
|
|
|
—
|
|
|
(1,300,000
|
)
|
|
650,000
|
|
||||
TBA dollar roll positions
|
|
795,000
|
|
|
4,580,000
|
|
|
(4,610,000
|
)
|
|
765,000
|
|
||||
TBA economic hedges
|
|
150,000
|
|
|
—
|
|
|
(150,000
|
)
|
|
—
|
|
||||
Options on U.S. Treasury futures
|
|
—
|
|
|
300,000
|
|
|
—
|
|
|
300,000
|
|
(1)
|
The Eurodollar futures notional amounts represent the total notional of the 3-month contracts all of which expire in 2018. The maximum notional outstanding for any future 3-month period did not exceed $650,000 during the period indicated.
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||
Type of Derivative Instrument
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Receive-fixed interest rate swaps
|
|
$
|
(376
|
)
|
|
$
|
979
|
|
|
$
|
(1,505
|
)
|
|
$
|
845
|
|
Pay-fixed interest rate swaps
|
|
20,947
|
|
|
(18,498
|
)
|
|
70,319
|
|
|
(18,189
|
)
|
||||
Eurodollar futures
|
|
170
|
|
|
—
|
|
|
2,075
|
|
|
—
|
|
||||
TBA dollar roll positions
|
|
(965
|
)
|
|
1,717
|
|
|
(13,052
|
)
|
|
1,717
|
|
||||
TBA economic hedges
|
|
—
|
|
|
—
|
|
|
293
|
|
|
—
|
|
||||
Options on U.S. Treasury futures
|
|
891
|
|
|
—
|
|
|
891
|
|
|
—
|
|
||||
Gain (loss) on derivative instruments, net
|
|
$
|
20,667
|
|
|
$
|
(15,802
|
)
|
|
$
|
59,021
|
|
|
$
|
(15,627
|
)
|
|
Offsetting of Assets
|
||||||||||||||||||||||
|
Gross Amount of Recognized Assets
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Assets Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Received as Collateral
|
|
Cash Received as Collateral
|
|||||||||||||||||||||
June 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
985
|
|
|
$
|
—
|
|
|
$
|
985
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
985
|
|
Eurodollar Futures
|
967
|
|
|
—
|
|
|
967
|
|
|
—
|
|
|
(967
|
)
|
|
—
|
|
||||||
TBA securities
|
2,034
|
|
|
—
|
|
|
2,034
|
|
|
—
|
|
|
(266
|
)
|
|
1,768
|
|
||||||
Options on U.S. Treasury futures
|
3,656
|
|
|
—
|
|
|
3,656
|
|
|
—
|
|
|
(3,656
|
)
|
|
—
|
|
||||||
Derivative assets
|
$
|
7,642
|
|
|
$
|
—
|
|
|
$
|
7,642
|
|
|
$
|
—
|
|
|
$
|
(4,889
|
)
|
|
$
|
2,753
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
791
|
|
|
$
|
—
|
|
|
$
|
791
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
791
|
|
Eurodollar Futures
|
666
|
|
|
—
|
|
|
666
|
|
|
—
|
|
|
(666
|
)
|
|
—
|
|
||||||
TBA securities
|
1,483
|
|
|
—
|
|
|
1,483
|
|
|
(180
|
)
|
|
—
|
|
|
1,303
|
|
||||||
Options on U.S. Treasury futures
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivative assets
|
$
|
2,940
|
|
|
$
|
—
|
|
|
$
|
2,940
|
|
|
$
|
(180
|
)
|
|
$
|
(666
|
)
|
|
$
|
2,094
|
|
|
Offsetting of Liabilities
|
||||||||||||||||||||||
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet
(1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
June 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
TBA securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Derivative liabilities
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
TBA securities
|
269
|
|
|
—
|
|
|
269
|
|
|
(180
|
)
|
|
—
|
|
|
89
|
|
||||||
Derivative liabilities
|
$
|
269
|
|
|
$
|
—
|
|
|
$
|
269
|
|
|
$
|
(180
|
)
|
|
$
|
—
|
|
|
$
|
89
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.
|
•
|
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
|
•
|
Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
|
•
|
Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
|
|
June 30, 2018
|
||||||||||||||
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
Assets carried at fair value:
|
|
|
|
|
|
|
|
||||||||
Investments in securities:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
2,759,894
|
|
|
$
|
—
|
|
|
$
|
2,753,321
|
|
|
$
|
6,573
|
|
U.S. Treasuries
|
57,923
|
|
|
57,923
|
|
|
—
|
|
|
—
|
|
||||
Derivative assets:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
985
|
|
|
—
|
|
|
985
|
|
|
—
|
|
||||
Eurodollar futures
|
967
|
|
|
967
|
|
|
—
|
|
|
—
|
|
||||
TBA securities
|
2,034
|
|
|
—
|
|
|
2,034
|
|
|
—
|
|
||||
Options on U.S. Treasury futures
|
3,656
|
|
|
3,656
|
|
|
—
|
|
|
—
|
|
||||
Total assets carried at fair value
|
$
|
2,825,459
|
|
|
$
|
62,546
|
|
|
$
|
2,756,340
|
|
|
$
|
6,573
|
|
|
|
|
|
|
|
|
|
||||||||
Total liabilities carried at fair value
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2017
|
||||||||||||||
|
Fair Value
|
|
Level 1 - Unadjusted Quoted Prices in Active Markets
|
|
Level 2 - Observable Inputs
|
|
Level 3 - Unobservable Inputs
|
||||||||
Assets carried at fair value:
|
|
|
|
|
|
|
|
||||||||
Investments in securities:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
3,026,989
|
|
|
$
|
—
|
|
|
$
|
3,019,746
|
|
|
$
|
7,243
|
|
U.S. Treasuries
|
146,530
|
|
|
146,530
|
|
|
—
|
|
|
—
|
|
||||
Derivative assets:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
791
|
|
|
—
|
|
|
791
|
|
|
—
|
|
||||
Eurodollar futures
|
666
|
|
|
666
|
|
|
—
|
|
|
—
|
|
||||
TBA securities
|
1,483
|
|
|
—
|
|
|
1,483
|
|
|
—
|
|
||||
Total assets carried at fair value
|
$
|
3,176,459
|
|
|
$
|
147,196
|
|
|
$
|
3,022,020
|
|
|
$
|
7,243
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities carried at fair value:
|
|
|
|
|
|
|
|
||||||||
TBA securities
|
269
|
|
|
—
|
|
|
269
|
|
|
—
|
|
||||
Total liabilities carried at fair value
|
$
|
269
|
|
|
$
|
—
|
|
|
$
|
269
|
|
|
$
|
—
|
|
|
Six Months Ended
|
||
|
June 30, 2018
|
||
Balance as of beginning of period
|
$
|
7,243
|
|
Unrealized loss included in OCI
|
(582
|
)
|
|
Principal payments
|
(692
|
)
|
|
Accretion
|
604
|
|
|
Balance as of end of period
|
$
|
6,573
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
2,759,894
|
|
|
$
|
2,759,894
|
|
|
$
|
3,026,989
|
|
|
$
|
3,026,989
|
|
U.S. Treasuries
|
57,923
|
|
|
57,923
|
|
|
146,530
|
|
|
146,530
|
|
||||
Mortgage loans held for investment, net
(1)
|
13,628
|
|
|
10,563
|
|
|
15,738
|
|
|
12,973
|
|
||||
Derivative assets
|
7,642
|
|
|
7,642
|
|
|
2,940
|
|
|
2,940
|
|
||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Repurchase agreements
(2)
|
$
|
2,514,984
|
|
|
$
|
2,514,984
|
|
|
$
|
2,565,902
|
|
|
$
|
2,565,902
|
|
Non-recourse collateralized financing
(1)
|
4,393
|
|
|
4,430
|
|
|
5,520
|
|
|
5,554
|
|
||||
Derivative liabilities
|
—
|
|
|
—
|
|
|
269
|
|
|
269
|
|
(1)
|
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.
|
(2)
|
The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.
|
|
Three Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2018
|
|
2017
|
||||||||||
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
||||||
Restricted stock outstanding as of beginning of period
|
334,509
|
|
|
$
|
6.42
|
|
|
386,151
|
|
|
$
|
7.05
|
|
Restricted stock granted
|
36,924
|
|
|
6.28
|
|
|
29,720
|
|
|
6.73
|
|
||
Restricted stock vested
|
(29,720
|
)
|
|
6.73
|
|
|
(62,768
|
)
|
|
7.14
|
|
||
Restricted stock outstanding as of end of period
|
341,713
|
|
|
$
|
6.37
|
|
|
353,103
|
|
|
$
|
7.01
|
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2018
|
|
2017
|
||||||||||
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
||||||
Restricted stock outstanding as of beginning of period
|
353,103
|
|
|
$
|
7.01
|
|
|
553,396
|
|
|
$
|
7.55
|
|
Restricted stock granted
|
213,157
|
|
|
6.28
|
|
|
138,166
|
|
|
6.76
|
|
||
Restricted stock vested
|
(224,547
|
)
|
|
7.28
|
|
|
(338,459
|
)
|
|
7.80
|
|
||
Restricted stock outstanding as of end of period
|
341,713
|
|
|
$
|
6.37
|
|
|
353,103
|
|
|
$
|
7.01
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
Agency MBS
(1)
|
|
CMBS IO
(2)
|
|
Non-Agency Other
(3)
|
|||||||||||||||||||||
Quarter Ended
|
|
Yield
|
|
Cost
(4)
|
|
Net Yield
|
|
Yield
|
|
Cost
(4)
|
|
Net Yield
|
|
Yield
|
|
Cost
(4)
|
|
Net Yield
|
|||||||||
June 30, 2018
|
|
2.94
|
%
|
|
1.93
|
%
|
|
1.01
|
%
|
|
3.78
|
%
|
|
2.59
|
%
|
|
1.19
|
%
|
|
30.67
|
%
|
|
—
|
%
|
|
30.67
|
%
|
March 31, 2018
|
|
2.85
|
%
|
|
1.60
|
%
|
|
1.25
|
%
|
|
3.84
|
%
|
|
2.33
|
%
|
|
1.51
|
%
|
|
11.37
|
%
|
|
2.47
|
%
|
|
8.90
|
%
|
December 31, 2017
|
|
2.77
|
%
|
|
1.36
|
%
|
|
1.41
|
%
|
|
3.82
|
%
|
|
2.13
|
%
|
|
1.69
|
%
|
|
10.21
|
%
|
|
2.24
|
%
|
|
7.97
|
%
|
September 30, 2017
|
|
2.51
|
%
|
|
1.27
|
%
|
|
1.24
|
%
|
|
3.89
|
%
|
|
2.10
|
%
|
|
1.79
|
%
|
|
9.21
|
%
|
|
2.24
|
%
|
|
6.97
|
%
|
June 30, 2017
|
|
2.39
|
%
|
|
1.03
|
%
|
|
1.36
|
%
|
|
3.87
|
%
|
|
1.89
|
%
|
|
1.98
|
%
|
|
8.54
|
%
|
|
2.05
|
%
|
|
6.49
|
%
|
(1)
|
Includes Agency RMBS and CMBS.
|
(3)
|
Includes privately-issued RMBS and CMBS.
|
(4)
|
Excludes net periodic interest benefit/cost of interest rate swaps used to economically hedge the interest rate risk of using repurchase agreement borrowings to finance our investments.
|
|
Three Months Ended
|
||||||
($ in thousands, except per share amounts)
|
June 30, 2018
|
|
March 31, 2018
|
||||
GAAP net income to common shareholders
|
$
|
12,710
|
|
|
$
|
41,367
|
|
Less:
|
|
|
|
||||
Change in fair value of derivative instruments, net
(1)
|
(14,715
|
)
|
|
(34,841
|
)
|
||
Loss on sale of investments, net
|
12,444
|
|
|
3,775
|
|
||
De-designated cash flow hedge accretion
(2)
|
(48
|
)
|
|
(48
|
)
|
||
Fair value adjustments, net
|
(27
|
)
|
|
(29
|
)
|
||
Core net operating income to common shareholders
|
$
|
10,364
|
|
|
$
|
10,224
|
|
|
|
|
|
||||
Weighted average common shares outstanding
|
56,295
|
|
|
55,871
|
|
||
Core net operating income per common share
|
$
|
0.18
|
|
|
$
|
0.18
|
|
(1)
|
Amount represents net realized and unrealized gains and losses on derivatives and excludes net periodic interest costs related to these instruments.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Three Months Ended
|
||||||||||||
|
June 30, 2018
|
|
March 31, 2018
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
GAAP interest expense/cost of funds
|
$
|
14,175
|
|
|
2.06
|
%
|
|
$
|
11,595
|
|
|
1.75
|
%
|
Add: net periodic interest (benefit) cost
(1)
|
(2,333
|
)
|
|
(0.35
|
)%
|
|
220
|
|
|
0.01
|
%
|
||
Less: de-designated cash flow hedge accretion
(2)
|
48
|
|
|
0.01
|
%
|
|
48
|
|
|
0.03
|
%
|
||
Adjusted interest expense/adjusted cost of funds
|
$
|
11,890
|
|
|
1.72
|
%
|
|
$
|
11,863
|
|
|
1.79
|
%
|
(1)
|
Amount represents net periodic interest benefit (cost) of effective interest rate swaps outstanding during the period and excludes unrealized gains and losses from changes in fair value of derivatives and realized gains and losses on terminated derivatives.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
(1)
|
Amount represents net periodic interest benefit (cost) of effective interest rate swaps outstanding during the period and excludes unrealized gains and losses from changes in fair value of derivatives and realized gains and losses on terminated derivatives.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
Agency RMBS, fixed-rate
|
$
|
1,163,875
|
|
|
$
|
1,134,783
|
|
|
$
|
903,270
|
|
|
$
|
898,678
|
|
TBAs, fixed-rate
(1)
|
782,408
|
|
|
784,442
|
|
|
829,425
|
|
|
830,908
|
|
||||
Agency RMBS, adjustable rate
|
38,966
|
|
|
39,830
|
|
|
289,304
|
|
|
285,583
|
|
||||
Agency CMBS, fixed-rate
|
1,008,887
|
|
|
965,524
|
|
|
1,134,409
|
|
|
1,124,351
|
|
||||
CMBS IO
(2)
|
607,452
|
|
|
613,184
|
|
|
683,833
|
|
|
692,522
|
|
||||
Non-Agency other
(3)
|
4,890
|
|
|
6,573
|
|
|
23,536
|
|
|
25,855
|
|
||||
U.S. Treasuries
|
57,973
|
|
|
57,923
|
|
|
148,267
|
|
|
146,530
|
|
||||
Mortgage loans held for investment, net
(4)
|
13,628
|
|
|
10,563
|
|
|
15,738
|
|
|
12,973
|
|
||||
Total investment portfolio including TBA dollar roll positions
|
$
|
3,678,079
|
|
|
$
|
3,612,822
|
|
|
$
|
4,027,782
|
|
|
$
|
4,017,400
|
|
(1)
|
Consists of long positions in TBAs used for investment purposes at their implied cost basis and implied market value, respectively, as if settled and excludes short positions in TBAs used for economic hedging purposes. All TBAs are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes non-Agency CMBS and RMBS.
|
(4)
|
Recorded on consolidated balance sheet at amortized cost.
|
|
Agency RMBS
|
|
Agency CMBS
|
|
CMBS IO
(3)
|
|
Non-Agency Other
(4)
|
|
Total
|
||||||||||||||
($ in thousands)
|
30-Year Fixed
Rate
(1) (2)
|
|
Adjustable Rate
|
|
|
|
|
||||||||||||||||
Balance as of December 31, 2017
|
$
|
1,729,586
|
|
|
$
|
285,583
|
|
|
$
|
1,124,351
|
|
|
$
|
692,522
|
|
|
$
|
25,855
|
|
|
$
|
3,857,897
|
|
Purchases
|
254,495
|
|
|
—
|
|
|
—
|
|
|
2,814
|
|
|
—
|
|
|
257,309
|
|
||||||
Principal payments
|
(38,802
|
)
|
|
(23,670
|
)
|
|
(13,564
|
)
|
|
—
|
|
|
(19,296
|
)
|
|
(95,332
|
)
|
||||||
Sales
|
—
|
|
|
(225,622
|
)
|
|
(110,810
|
)
|
|
(8,644
|
)
|
|
—
|
|
|
(345,076
|
)
|
||||||
(Amortization) accretion
|
(2,105
|
)
|
|
(1,046
|
)
|
|
(1,148
|
)
|
|
(70,552
|
)
|
|
651
|
|
|
(74,200
|
)
|
||||||
Change in fair value
|
(23,949
|
)
|
|
4,585
|
|
|
(33,305
|
)
|
|
(2,956
|
)
|
|
(637
|
)
|
|
(56,262
|
)
|
||||||
Balance as of June 30, 2018
|
$
|
1,919,225
|
|
|
$
|
39,830
|
|
|
$
|
965,524
|
|
|
$
|
613,184
|
|
|
$
|
6,573
|
|
|
$
|
3,544,336
|
|
(1)
|
Includes securities pending settlement as of dates indicated.
|
(2)
|
Includes long positions in TBAs used for investment purposes at their implied market value as if settled and excludes short positions in TBAs used for economic hedging purposes. All TBAs are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
(3)
|
Includes Agency and non-Agency issued securities.
|
(4)
|
Includes non-Agency CMBS and RMBS.
|
|
|
June 30, 2018
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
Weighted Average Based on Par
|
|||||||||||||||||
Coupon
|
|
Par
|
|
Amortized Cost/
Implied Cost
Basis
(1)(3)
|
|
Fair
Value
(2)(3)
|
|
Average Original Loan
Balance
(4)
|
|
Loan Age
(in months)
(4)
|
|
3 Month
CPR
(4)(5)
|
|
Duration
(6)
|
|||||||||||
|
|
($ in thousands)
|
|
|
|
|
|
|
|||||||||||||||||
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.0%
|
|
$
|
234,364
|
|
|
$
|
236,037
|
|
|
$
|
227,408
|
|
|
$
|
233,581
|
|
|
20
|
|
|
7.5
|
%
|
|
6.66
|
|
4.0%
|
|
888,778
|
|
|
927,838
|
|
|
907,375
|
|
|
289,641
|
|
|
8
|
|
|
5.2
|
%
|
|
4.72
|
|
||||
TBA 4.0%
|
|
515,000
|
|
|
523,267
|
|
|
524,559
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
4.50
|
|
||||
TBA 4.5%
|
|
250,000
|
|
|
259,141
|
|
|
259,883
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
3.69
|
|
||||
Total 30-year fixed-rate
|
|
$
|
1,888,142
|
|
|
$
|
1,946,283
|
|
|
$
|
1,919,225
|
|
|
$
|
277,943
|
|
|
11
|
|
|
5.7
|
%
|
|
4.76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustable-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.9%
(7)
|
|
$
|
37,921
|
|
|
$
|
38,966
|
|
|
$
|
39,830
|
|
|
$
|
207,782
|
|
|
125
|
|
|
20.4
|
%
|
|
0.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Agency RMBS (including TBA dollar roll positions)
|
|
$
|
1,926,063
|
|
|
$
|
1,985,249
|
|
|
$
|
1,959,055
|
|
|
$
|
275,652
|
|
|
14
|
|
|
6.1
|
%
|
|
4.68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
December 31, 2017
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
Weighted Average Based on Par
|
|||||||||||||||||
Coupon
|
|
Par
|
|
Amortized Cost/Implied Cost Basis
(1)(3)
|
|
Fair
Value
(2)(3)
|
|
Average Original Loan
Balance
(4)
|
|
Loan Age
(in months)
(4)
|
|
3 Month
CPR
(4)(5)
|
|
Duration
(6)
|
|||||||||||
|
|
($ in thousands)
|
|
|
|
|
|
|
|||||||||||||||||
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.0%
|
|
$
|
244,374
|
|
|
$
|
246,155
|
|
|
$
|
244,818
|
|
|
$
|
233,584
|
|
|
13
|
|
|
5.0
|
%
|
|
6.30
|
|
4.0%
|
|
623,293
|
|
|
657,114
|
|
|
653,860
|
|
|
274,965
|
|
|
4
|
|
|
4.0
|
%
|
|
3.91
|
|
||||
TBA 4.0%
|
|
795,000
|
|
|
829,425
|
|
|
830,908
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
2.95
|
|
||||
Total 30-year fixed-rate
|
|
$
|
1,662,667
|
|
|
$
|
1,732,694
|
|
|
$
|
1,729,586
|
|
|
$
|
263,310
|
|
|
6
|
|
|
4.3
|
%
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustable-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.1%
(7)
|
|
$
|
278,886
|
|
|
$
|
289,305
|
|
|
$
|
285,583
|
|
|
$
|
271,516
|
|
|
74
|
|
|
16.0
|
%
|
|
2.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Agency RMBS (including TBA dollar roll positions)
|
|
$
|
1,941,553
|
|
|
$
|
2,021,999
|
|
|
$
|
2,015,169
|
|
|
$
|
265,306
|
|
|
23
|
|
|
7.1
|
%
|
|
3.58
|
|
(1)
|
Implied cost basis of TBA dollar roll positions represents the forward price to be paid for the underlying Agency MBS as if settled.
|
(2)
|
Fair value of TBA dollar roll positions is the implied market value of the underlying Agency security as of the end of the period if settled.
|
(3)
|
The net carrying value of TBA dollar roll positions, which is the difference between their implied market value and implied cost basis, was
$2.0 million
as of
June 30, 2018
and
$1.5 million
as of
December 31, 2017
and is included on the consolidated balance sheet within “derivative assets”.
|
(4)
|
TBA dollar roll positions are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.
|
(5)
|
Constant prepayment rate (“CPR”) represents the 3-month CPR of Agency RMBS held as of date indicated. Securities with no prepayment history are excluded from this calculation.
|
(6)
|
Duration measures the sensitivity of a security's price to the change in interest rates and represents the percent change in price of a security for a 100 basis point increase in interest rates. We calculate duration using third-party financial models and empirical data. Different models and methodologies can produce different estimates of duration for the same securities.
|
(7)
|
Coupon of adjustable-rate Agency RMBS represents the weighted average coupon based on amortized cost.
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity
(1)
|
||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
2008 and prior
|
$
|
28,578
|
|
|
$
|
25,924
|
|
|
39
|
|
$
|
34,065
|
|
|
$
|
31,026
|
|
|
41
|
2009 to 2012
|
85,913
|
|
|
88,052
|
|
|
26
|
|
106,619
|
|
|
109,234
|
|
|
27
|
||||
2013 to 2014
|
18,489
|
|
|
18,853
|
|
|
79
|
|
20,237
|
|
|
20,600
|
|
|
82
|
||||
2015
|
352,644
|
|
|
354,988
|
|
|
102
|
|
468,296
|
|
|
469,657
|
|
|
103
|
||||
2016
|
238,856
|
|
|
240,439
|
|
|
104
|
|
239,139
|
|
|
240,831
|
|
|
110
|
||||
2017
|
281,344
|
|
|
284,569
|
|
|
112
|
|
282,112
|
|
|
285,527
|
|
|
118
|
||||
|
$
|
1,005,824
|
|
|
$
|
1,012,825
|
|
|
96
|
|
$
|
1,150,468
|
|
|
$
|
1,156,875
|
|
|
99
|
(1)
|
Months to estimated maturity is an average weighted by the amortized cost of the investment.
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||||
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL
(1)
|
||||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2010
|
$
|
4,984
|
|
|
$
|
5,027
|
|
|
11
|
|
|
$
|
6,421
|
|
|
$
|
6,554
|
|
|
13
|
|
2011
|
20,966
|
|
|
21,826
|
|
|
16
|
|
|
25,652
|
|
|
26,720
|
|
|
18
|
|
||||
2012
|
58,948
|
|
|
59,598
|
|
|
20
|
|
|
71,615
|
|
|
72,913
|
|
|
22
|
|
||||
2013
|
83,513
|
|
|
83,720
|
|
|
25
|
|
|
103,730
|
|
|
104,568
|
|
|
28
|
|
||||
2014
|
152,220
|
|
|
153,472
|
|
|
32
|
|
|
171,285
|
|
|
173,043
|
|
|
34
|
|
||||
2015
|
157,409
|
|
|
159,536
|
|
|
37
|
|
|
170,663
|
|
|
172,974
|
|
|
40
|
|
||||
2016
|
77,758
|
|
|
78,146
|
|
|
44
|
|
|
82,698
|
|
|
83,444
|
|
|
47
|
|
||||
2017
|
49,053
|
|
|
49,285
|
|
|
50
|
|
|
51,769
|
|
|
52,306
|
|
|
53
|
|
||||
2018
|
2,601
|
|
|
2,574
|
|
|
75
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
607,452
|
|
|
$
|
613,184
|
|
|
34
|
|
|
$
|
683,833
|
|
|
$
|
692,522
|
|
|
36
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
($ in thousands)
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
|
Fair Value
|
|
Amount Pledged
|
|
Related Borrowings
|
||||||||||||
Non-Agency CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
A
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
18,212
|
|
|
$
|
18,212
|
|
|
$
|
15,508
|
|
|||
Below A/Not Rated
|
—
|
|
|
—
|
|
|
—
|
|
|
6,552
|
|
|
—
|
|
|
—
|
|
||||||
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
24,764
|
|
|
$
|
18,212
|
|
|
$
|
15,508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Non-Agency CMBS IO:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
AAA
|
$
|
222,913
|
|
|
$
|
222,944
|
|
|
$
|
188,920
|
|
|
$
|
259,155
|
|
|
$
|
259,151
|
|
|
$
|
218,995
|
|
AA
|
38,926
|
|
|
38,349
|
|
|
32,189
|
|
|
42,486
|
|
|
—
|
|
|
—
|
|
||||||
A
|
703
|
|
|
703
|
|
|
610
|
|
|
735
|
|
|
735
|
|
|
641
|
|
||||||
Below A/Not Rated
|
9,149
|
|
|
9,149
|
|
|
7,919
|
|
|
9,840
|
|
|
51,685
|
|
|
44,058
|
|
||||||
|
$
|
271,691
|
|
|
$
|
271,145
|
|
|
$
|
229,638
|
|
|
$
|
312,216
|
|
|
$
|
311,571
|
|
|
$
|
263,694
|
|
|
As of
December 31, 2017
|
|
Six Months Ended
|
|
As of
June 30, 2018
|
||||||||||
|
June 30, 2018
|
|
|||||||||||||
($ in thousands)
|
|
Unrealized Gain (Loss)
|
|
Realized Gain (Loss)
(1)
|
|
||||||||||
Fixed-rate Agency RMBS
|
$
|
(4,592
|
)
|
|
$
|
(24,500
|
)
|
|
$
|
—
|
|
|
$
|
(29,092
|
)
|
Adjustable-rate Agency RMBS
|
(3,721
|
)
|
|
12,370
|
|
|
$
|
(7,785
|
)
|
|
864
|
|
|||
Agency CMBS
|
(10,058
|
)
|
|
(31,253
|
)
|
|
(2,052
|
)
|
|
(43,363
|
)
|
||||
CMBS IO
(2)
|
8,689
|
|
|
(3,008
|
)
|
|
51
|
|
|
5,732
|
|
||||
Non-Agency other
(3)
|
2,319
|
|
|
(636
|
)
|
|
—
|
|
|
1,683
|
|
||||
U.S. Treasuries
|
(1,737
|
)
|
|
8,120
|
|
|
(6,433
|
)
|
|
(50
|
)
|
||||
De-designated cash flow hedges
|
403
|
|
|
—
|
|
|
(96
|
)
|
|
307
|
|
||||
Total
|
$
|
(8,697
|
)
|
|
$
|
(38,907
|
)
|
|
$
|
(16,315
|
)
|
|
$
|
(63,919
|
)
|
|
Three Months Ended
|
||||||||||||||||||||
|
June 30,
|
||||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||||
($ in thousands)
|
Interest Income/Expense
|
|
Average Balance
(1)(2)
|
|
Effective Yield/
Cost of
Funds
(3)(4)
|
|
Interest Income/Expense
|
|
Average Balance
(1)(2)
|
|
Effective Yield/
Cost of
Funds
(3)(4)
|
||||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency RMBS-fixed rate
|
$
|
9,190
|
|
|
$
|
1,135,365
|
|
|
3.24
|
%
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
Agency CMBS-fixed rate
|
7,267
|
|
|
1,011,945
|
|
|
2.80
|
%
|
|
9,239
|
|
|
1,278,032
|
|
|
2.78
|
%
|
||||
Agency RMBS-adjustable rate
|
1,332
|
|
|
254,850
|
|
|
2.14
|
%
|
|
4,277
|
|
|
983,587
|
|
|
1.89
|
%
|
||||
CMBS IO
(5)
|
6,298
|
|
|
632,376
|
|
|
3.78
|
%
|
|
8,306
|
|
|
756,367
|
|
|
3.87
|
%
|
||||
Non-Agency other
(6)
|
446
|
|
|
5,022
|
|
|
30.67
|
%
|
|
2,762
|
|
|
71,220
|
|
|
8.54
|
%
|
||||
Treasuries
|
1,001
|
|
|
156,420
|
|
|
2.57
|
%
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||||
Other investments
(7)
|
388
|
|
|
14,576
|
|
|
3.99
|
%
|
|
272
|
|
|
17,808
|
|
|
3.85
|
%
|
||||
Total:
|
$
|
25,922
|
|
|
$
|
3,210,554
|
|
|
3.13
|
%
|
|
$
|
24,856
|
|
|
$
|
3,107,014
|
|
|
2.90
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Repurchase agreements
|
$
|
14,181
|
|
|
$
|
2,716,097
|
|
|
2.07
|
%
|
|
$
|
8,763
|
|
|
$
|
2,753,019
|
|
|
1.26
|
%
|
Non-recourse collateralized financing
|
42
|
|
|
5,002
|
|
|
2.73
|
%
|
|
24
|
|
|
6,003
|
|
|
1.77
|
%
|
||||
De-designated cash flow hedge accretion
(8)
|
(48
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
|
(73
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
||||
Total:
|
$
|
14,175
|
|
|
$
|
2,721,099
|
|
|
2.06
|
%
|
|
$
|
8,714
|
|
|
$
|
2,759,022
|
|
|
1.25
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net interest income/net interest spread
|
$
|
11,747
|
|
|
|
|
1.07
|
%
|
|
$
|
16,142
|
|
|
|
|
1.65
|
%
|
(1)
|
Average balance for assets is calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.
|
(3)
|
Effective yield is calculated by dividing the sum of gross interest income and scheduled premium amortization/discount accretion (both of which are annualized for any reporting period less than 12 months) and prepayment compensation and premium amortization/discount accretion adjustments (collectively, "prepayment adjustments"), which are not annualized, by the average balance of asset type outstanding during the reporting period.
|
(4)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
(5)
|
Includes Agency and non-Agency issued securities.
|
(6)
|
Includes privately-issued RMBS and CMBS.
|
(7)
|
Interest income for other investments consists of $143 from mortgage loans held for investment, net and $245 from cash and cash equivalents for the
three months ended
June 30, 2018
compared to $176 and $96 for the
three months ended
June 30, 2017
, respectively. Average balances and yields shown for other investments includes amortized cost of mortgage loans held for investment and excludes cash.
|
(8)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP which represents the accretion of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 related to derivatives for which we discontinued cash flow hedge accounting.
|
|
Three Months Ended
|
||||||||||||||
|
June 30, 2018 Compared to June 30, 2017
|
||||||||||||||
|
Increase (Decrease) Due to Change In
|
|
Total Change in Interest Income/Expense
|
||||||||||||
($ in thousands)
|
Rate
|
|
Volume
|
|
Prepayment Adjustments
(1)
|
|
|||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
||||||||
Agency RMBS-fixed rate
|
$
|
—
|
|
|
$
|
9,190
|
|
|
$
|
—
|
|
|
$
|
9,190
|
|
Agency CMBS-fixed rate
|
100
|
|
|
(1,849
|
)
|
|
(223
|
)
|
|
(1,972
|
)
|
||||
Agency RMBS-adjustable rate
|
140
|
|
|
(3,525
|
)
|
|
440
|
|
|
(2,945
|
)
|
||||
CMBS IO
(2)
|
29
|
|
|
(1,149
|
)
|
|
(888
|
)
|
|
(2,008
|
)
|
||||
Non-Agency other
(3)
|
284
|
|
|
(1,026
|
)
|
|
(1,574
|
)
|
|
(2,316
|
)
|
||||
Treasuries
|
—
|
|
|
1,001
|
|
|
—
|
|
|
1,001
|
|
||||
Other investments
(4)
|
7
|
|
|
118
|
|
|
(9
|
)
|
|
116
|
|
||||
Total increase (decrease) in interest income
|
$
|
560
|
|
|
$
|
2,760
|
|
|
$
|
(2,254
|
)
|
|
$
|
1,066
|
|
|
|
|
|
|
|
|
|
|
|||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|||||||
Repurchase agreements
|
$
|
5,536
|
|
|
$
|
(118
|
)
|
|
$
|
—
|
|
|
$
|
5,418
|
|
Non-recourse collateralized financing, net of other
(5)
|
53
|
|
|
(10
|
)
|
|
—
|
|
|
43
|
|
||||
Total increase (decrease) in interest expense
|
5,589
|
|
|
(128
|
)
|
|
—
|
|
|
5,461
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total net (decrease) increase in net interest income
|
$
|
(5,029
|
)
|
|
$
|
2,888
|
|
|
$
|
(2,254
|
)
|
|
$
|
(4,395
|
)
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for adjustable-rate RMBS and prepayment compensation, net of amortization adjustments for CMBS and CMBS IO and are not annualized in the calculation of effective yield
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes privately-issued RMBS and CMBS.
|
(4)
|
Increase of $149 thousand in other interest income from cash and cash equivalents is included as a change in volume.
|
(5)
|
Includes decrease of $(25) thousand in de-designated cash flow hedge accretion as a change in rate.
|
|
Three Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2018
|
|
2017
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
Net interest income
|
$
|
11,747
|
|
|
1.07
|
%
|
|
$
|
16,142
|
|
|
1.65
|
%
|
Add: TBA drop income
|
3,619
|
|
|
0.10
|
%
|
|
1,351
|
|
|
0.05
|
%
|
||
Add: net periodic interest benefit (cost)
(1)
|
2,333
|
|
|
0.35
|
%
|
|
(1,352
|
)
|
|
(0.20
|
)%
|
||
De-designated cash flow hedge accretion
(2)
|
(48
|
)
|
|
(0.01
|
)%
|
|
(73
|
)
|
|
(0.01
|
)%
|
||
Adjusted net interest income
|
$
|
17,651
|
|
|
1.51
|
%
|
|
$
|
16,068
|
|
|
1.49
|
%
|
(1)
|
Amount represents net periodic interest benefit (cost) of effective interest rate swaps outstanding during the period and excludes unrealized gains and losses from changes in fair value of derivatives and realized gains and losses on terminated derivatives.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP which represents the accretion of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 related to derivatives for which we discontinued cash flow hedge accounting.
|
|
Three Months Ended
|
|
Three Months Ended June 30, 2018 Compared to Three Months Ended June 30, 2017
|
||||||||||||||||||||||
|
June 30,
|
|
|||||||||||||||||||||||
|
2018
|
|
2017
|
|
Total Change
|
|
Due to Change In
|
||||||||||||||||||
($ in thousands)
|
Amount
|
|
Average Yield/Cost
|
|
Amount
|
|
Average Yield/Cost
|
|
|
Rate
|
|
Volume
|
|||||||||||||
TBA implied interest income
(1)
|
$
|
6,771
|
|
|
3.61
|
%
|
|
$
|
1,951
|
|
|
2.92
|
%
|
|
$
|
4,820
|
|
|
$
|
1,293
|
|
|
$
|
3,527
|
|
TBA implied interest expense
(2)
|
3,152
|
|
|
1.68
|
%
|
|
600
|
|
|
0.90
|
%
|
|
2,552
|
|
|
1,468
|
|
|
1,084
|
|
|||||
TBA drop income/net yield
(3)
|
$
|
3,619
|
|
|
1.93
|
%
|
|
$
|
1,351
|
|
|
2.02
|
%
|
|
$
|
2,268
|
|
|
$
|
(175
|
)
|
|
$
|
2,443
|
|
Average amortized cost basis
|
$
|
742,111
|
|
|
|
|
$
|
264,261
|
|
|
|
|
|
|
|
|
|
(1)
|
Average yield for TBA dollar roll positions is extrapolated by adding average cost (Note 2) to the net yield (Note 3). Implied interest income is calculated by multiplying the average yield by the TBA cost basis outstanding during the period.
|
(2)
|
Average funding cost for TBA dollar roll positions is determined using the “price drop” between the near settling TBA contract and the price for the same contract with a later settlement date and market-based assumptions regarding the “cheapest-to-deliver” collateral that can satisfy the TBA contract, such as the security’s coupon, maturity, and projected prepayment rate
|
(3)
|
TBA net yield is calculated by dividing drop income by the average TBA cost basis outstanding during the period.
|
|
Six Months Ended
|
||||||||||||||||||||
|
June 30,
|
||||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||||
($ in thousands)
|
Interest Income/Expense
|
|
Average Balance
(1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
|
Interest Income/Expense
|
|
Average Balance
(1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
||||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency RMBS-fixed rate
|
$
|
16,292
|
|
|
$
|
1,019,891
|
|
|
3.19
|
%
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
Agency CMBS-fixed rate
|
14,895
|
|
|
1,046,882
|
|
|
2.81
|
%
|
|
17,160
|
|
|
1,223,391
|
|
|
2.77
|
%
|
||||
Agency RMBS-adjustable rate
|
2,921
|
|
|
268,733
|
|
|
2.15
|
%
|
|
8,551
|
|
|
1,069,565
|
|
|
1.75
|
%
|
||||
CMBS IO
(5)
|
13,240
|
|
|
650,799
|
|
|
3.90
|
%
|
|
16,627
|
|
|
756,998
|
|
|
4.07
|
%
|
||||
Non-Agency other
(6)
|
1,069
|
|
|
11,792
|
|
|
16.39
|
%
|
|
4,403
|
|
|
87,933
|
|
|
7.95
|
%
|
||||
U.S. Treasuries
|
1,967
|
|
|
162,431
|
|
|
2.44
|
%
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||||
Other investments
(7)
|
728
|
|
|
15,007
|
|
|
4.04
|
%
|
|
534
|
|
|
18,360
|
|
|
3.87
|
%
|
||||
Total:
|
$
|
51,112
|
|
|
$
|
3,175,535
|
|
|
3.14
|
%
|
|
$
|
47,275
|
|
|
$
|
3,156,247
|
|
|
2.89
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Repurchase agreements
|
$
|
25,795
|
|
|
$
|
2,681,100
|
|
|
1.91
|
%
|
|
$
|
16,359
|
|
|
$
|
2,798,125
|
|
|
1.16
|
%
|
Non-recourse collateralized financing
|
71
|
|
|
5,193
|
|
|
2.53
|
%
|
|
46
|
|
|
6,180
|
|
|
1.53
|
%
|
||||
De-designated cash flow hedge accretion
(8)
|
(96
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
|
(172
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
||||
Total:
|
$
|
25,770
|
|
|
$
|
2,686,293
|
|
|
1.91
|
%
|
|
$
|
16,233
|
|
|
$
|
2,804,305
|
|
|
1.15
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net interest income/net interest spread
|
$
|
25,342
|
|
|
|
|
1.23
|
%
|
|
$
|
31,042
|
|
|
|
|
1.74
|
%
|
(1)
|
Average balance for assets is calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.
|
(3)
|
Effective yield is calculated by dividing the sum of gross interest income and scheduled premium amortization/discount accretion (both of which are annualized for any reporting period less than 12 months) and prepayment compensation and premium amortization/discount accretion adjustments (collectively, "prepayment adjustments"), which are not annualized, by the average balance of asset type outstanding during the reporting period.
|
(4)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
(5)
|
Includes Agency and non-Agency issued securities.
|
(6)
|
Includes privately-issued RMBS and CMBS.
|
(7)
|
Interest income for other investments consists of $305 from mortgage loans held for investment, net and $423 from cash and cash equivalents for the
six months ended
June 30, 2018
compared to $361 and $173 for the
six months ended
June 30, 2017
, respectively. Average balances and yields shown for other investments includes amortized cost of mortgage loans held for investment and excludes cash.
|
(8)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP which represents the accretion of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 related to derivatives for which we discontinued cash flow hedge accounting.
|
|
Six Months Ended
|
||||||||||||||
|
June 30, 2018 Compared to June 30, 2017
|
||||||||||||||
|
Increase (Decrease) Due to Change In
|
|
Total Change in Interest Income/Expense
|
||||||||||||
($ in thousands)
|
Rate
|
|
Volume
|
|
Prepayment Adjustments
(1)
|
|
|||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
||||||||
Agency RMBS-fixed rate
|
$
|
—
|
|
|
$
|
16,292
|
|
|
$
|
—
|
|
|
$
|
16,292
|
|
Agency CMBS-fixed rate
|
233
|
|
|
(2,435
|
)
|
|
(63
|
)
|
|
(2,265
|
)
|
||||
Agency RMBS-adjustable rate
|
302
|
|
|
(7,634
|
)
|
|
1,702
|
|
|
(5,630
|
)
|
||||
CMBS IO
(2)
|
(92
|
)
|
|
(2,000
|
)
|
|
(1,295
|
)
|
|
(3,387
|
)
|
||||
Non-Agency other
(3)
|
480
|
|
|
(2,207
|
)
|
|
(1,607
|
)
|
|
(3,334
|
)
|
||||
Treasuries
|
—
|
|
|
1,967
|
|
|
—
|
|
|
1,967
|
|
||||
Other investments
(4)
|
16
|
|
|
186
|
|
|
(8
|
)
|
|
194
|
|
||||
Total increase (decrease) in interest income
|
$
|
939
|
|
|
$
|
4,169
|
|
|
$
|
(1,271
|
)
|
|
$
|
3,837
|
|
|
|
|
|
|
|
|
|
|
|||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|||||||
Repurchase agreements
|
$
|
10,120
|
|
|
$
|
(684
|
)
|
|
$
|
—
|
|
|
$
|
9,436
|
|
Non-recourse collateralized financing, net of other
(5)
|
111
|
|
|
(10
|
)
|
|
—
|
|
|
101
|
|
||||
Total increase (decrease) in interest expense
|
10,231
|
|
|
(694
|
)
|
|
—
|
|
|
9,537
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total net change in net interest income
|
$
|
(9,292
|
)
|
|
$
|
4,863
|
|
|
$
|
(1,271
|
)
|
|
$
|
(5,700
|
)
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for adjustable-rate RMBS and prepayment compensation, net of amortization adjustments for CMBS and CMBS IO and are not annualized in the calculation of effective yield
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes privately-issued RMBS and CMBS.
|
(4)
|
Increase of $250 thousand in other interest income from cash and cash equivalents is included as a change in volume.
|
(5)
|
Includes decrease of $(75) thousand in de-designated cash flow hedge accretion as a change in rate.
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2018
|
|
2017
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
Net interest income
|
$
|
25,342
|
|
|
1.23
|
%
|
|
$
|
31,042
|
|
|
1.74
|
%
|
Add: TBA drop income
|
7,352
|
|
|
0.09
|
%
|
|
1,351
|
|
|
0.01
|
%
|
||
Add: net periodic interest benefit (cost)
(1)
|
2,113
|
|
|
0.16
|
%
|
|
(1,967
|
)
|
|
(0.14
|
)%
|
||
De-designated cash flow hedge accretion
(2)
|
(96
|
)
|
|
(0.01
|
)%
|
|
(172
|
)
|
|
(0.01
|
)%
|
||
Adjusted net interest income
|
$
|
34,711
|
|
|
1.47
|
%
|
|
$
|
30,254
|
|
|
1.60
|
%
|
(1)
|
Amount represents net periodic interest benefit (cost) of effective interest rate swaps outstanding during the period and excludes unrealized gains and losses from changes in fair value of derivatives and realized gains and losses on terminated derivatives.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP which represents the accretion of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 related to derivatives for which we discontinued cash flow hedge accounting.
|
|
Six Months Ended
|
|
Six Months Ended June 30, 2018 Compared to Six Months Ended June 30, 2017
|
||||||||||||||||||||||
|
June 30,
|
|
|||||||||||||||||||||||
|
2018
|
|
2017
|
|
Total Change
|
|
Due to Change In
|
||||||||||||||||||
($ in thousands)
|
Amount
|
|
Average Yield/Cost
|
|
Amount
|
|
Average Yield/Cost
|
|
|
Rate
|
|
Volume
|
|||||||||||||
TBA implied interest income
(1)
|
$
|
13,821
|
|
|
3.42
|
%
|
|
$
|
1,946
|
|
|
2.91
|
%
|
|
$
|
11,875
|
|
|
$
|
2,045
|
|
|
$
|
9,830
|
|
TBA implied interest expense
(2)
|
6,469
|
|
|
1.60
|
%
|
|
595
|
|
|
0.89
|
%
|
|
5,874
|
|
|
2,870
|
|
|
3,004
|
|
|||||
TBA drop income/net yield
(3)
|
$
|
7,352
|
|
|
1.82
|
%
|
|
$
|
1,351
|
|
|
2.02
|
%
|
|
$
|
6,001
|
|
|
$
|
(825
|
)
|
|
$
|
6,826
|
|
Average amortized cost basis
|
$
|
804,122
|
|
|
|
|
$
|
132,860
|
|
|
|
|
|
|
|
|
|
(1)
|
Average yield for TBA dollar roll positions is extrapolated by adding average cost (Note 2) to the net yield (Note 3). Implied interest income is calculated by multiplying the average yield by the TBA cost basis outstanding during the period.
|
(2)
|
Average funding cost for TBA dollar roll positions is determined using the “price drop” between the near settling TBA contract and the price for the same contract with a later settlement date and market-based assumptions regarding the “cheapest-to-deliver” collateral that can satisfy the TBA contract, such as the security’s coupon, maturity, and projected prepayment rate anticipated for the collateral. TBA implied interest expense is calculated by multiplying the average funding cost by the average TBA cost basis outstanding during the period.
|
(3)
|
TBA net yield is calculated by dividing drop income by the average TBA cost basis outstanding during the period.
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||||||
($ in thousands)
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||||||
Interest rate derivatives:
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps:
|
|
|
|
|
|
|
|
|
||||||||||||
Net periodic interest costs
|
|
$
|
2,333
|
|
|
$
|
(1,352
|
)
|
|
$
|
2,113
|
|
|
$
|
(1,968
|
)
|
||||
Change in fair value
(1)
|
|
18,239
|
|
|
(16,167
|
)
|
|
66,702
|
|
|
(15,376
|
)
|
||||||||
Total interest rate swap gains (losses), net
|
|
20,572
|
|
|
(17,519
|
)
|
|
68,815
|
|
|
(17,344
|
)
|
||||||||
Eurodollar futures:
|
|
|
|
|
|
|
|
|
||||||||||||
Change in fair value
(1)
|
|
170
|
|
|
—
|
|
|
2,075
|
|
|
—
|
|
||||||||
TBA short positions (economic hedges):
|
|
|
|
|
|
|
|
|
||||||||||||
Change in fair value
(2)
|
|
—
|
|
|
—
|
|
|
293
|
|
|
—
|
|
||||||||
Total interest rate derivative gains (losses), net
|
|
20,742
|
|
|
(17,519
|
)
|
|
71,183
|
|
|
(17,344
|
)
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
TBA dollar roll positions:
|
|
|
|
|
|
|
|
|
||||||||||||
TBA drop income
|
|
3,619
|
|
|
1,351
|
|
|
7,352
|
|
|
1,351
|
|
||||||||
Change in fair value
(2)
|
|
(4,585
|
)
|
|
366
|
|
|
(20,405
|
)
|
|
366
|
|
||||||||
Total TBA dollar roll gains (losses), net
|
|
(966
|
)
|
|
1,717
|
|
|
(13,053
|
)
|
|
1,717
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Other derivatives:
|
|
|
|
|
|
|
|
|
||||||||||||
Options on U.S. Treasury futures
|
|
891
|
|
|
—
|
|
|
891
|
|
|
—
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Total gain on derivative instruments, net
|
|
$
|
20,667
|
|
|
$
|
(15,802
|
)
|
|
$
|
59,021
|
|
|
$
|
(15,627
|
)
|
(1)
|
Changes in fair value for interest rate swaps and Eurodollar futures include unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.
|
(2)
|
Changes in fair value for TBA positions include unrealized gains (losses) from open TBA contracts and realized gains (losses) on paired off or terminated positions.
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
($ in thousands)
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Average repurchase agreement borrowings outstanding
|
$
|
2,716,097
|
|
|
$
|
2,753,019
|
|
|
$
|
2,681,100
|
|
|
$
|
2,798,125
|
|
Average net TBAs outstanding - at cost
(1)
|
722,005
|
|
|
305,720
|
|
|
792,419
|
|
|
153,704
|
|
||||
Average borrowings and net TBAs outstanding
|
3,438,102
|
|
|
3,058,739
|
|
|
3,473,519
|
|
|
2,951,829
|
|
||||
Average notional amount of interest rate swaps outstanding (excluding forward starting swaps)
|
2,707,967
|
|
|
2,288,297
|
|
|
2,997,652
|
|
|
1,792,983
|
|
||||
Ratio of average interest rate swaps to average borrowings and net TBAs outstanding
(1)
|
0.8
|
|
|
0.7
|
|
|
0.9
|
|
|
0.6
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Average interest rate swap net pay-fixed rate (excluding forward starting swaps)
(1)
|
1.83
|
%
|
|
1.37
|
%
|
|
1.73
|
%
|
|
1.30
|
%
|
||||
Average interest rate swap net receive-floating rate
(2)
|
2.15
|
%
|
|
1.12
|
%
|
|
1.87
|
%
|
|
1.07
|
%
|
||||
Average interest rate swap net pay/(receive) rate
|
(0.32
|
)%
|
|
0.25
|
%
|
|
(0.14
|
)%
|
|
0.23
|
%
|
(1)
|
Because the Company executes TBA dollar roll transactions, which economically represent the purchase and financing of fixed-rate Agency RMBS, the average TBAs outstanding are included in the ratio calculation.
|
(2)
|
Net rates include receive-fixed (pay-floating) interest rate swaps.
|
|
Three Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
225,622
|
|
|
$
|
(7,785
|
)
|
|
$
|
271,417
|
|
|
$
|
(5,524
|
)
|
Agency CMBS
|
—
|
|
|
—
|
|
|
23,731
|
|
|
574
|
|
||||
Non-Agency CMBS IO
|
8,644
|
|
|
51
|
|
|
—
|
|
|
—
|
|
||||
Non-Agency CMBS
|
—
|
|
|
—
|
|
|
34,506
|
|
|
1,199
|
|
||||
Non-Agency RMBS
|
—
|
|
|
—
|
|
|
16,365
|
|
|
42
|
|
||||
U.S. Treasuries
|
149,171
|
|
|
(4,710
|
)
|
|
—
|
|
|
—
|
|
||||
|
$
|
383,437
|
|
|
$
|
(12,444
|
)
|
|
$
|
346,019
|
|
|
$
|
(3,709
|
)
|
|
|
|
|
|
|
|
|
||||||||
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
|
Amortized cost basis sold
|
|
(Loss) gain on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
225,622
|
|
|
$
|
(7,785
|
)
|
|
$
|
330,289
|
|
|
$
|
(7,232
|
)
|
Agency CMBS
|
110,810
|
|
|
(2,052
|
)
|
|
23,731
|
|
|
574
|
|
||||
Non-Agency CMBS IO
|
8,644
|
|
|
51
|
|
|
—
|
|
|
—
|
|
||||
Non-Agency CMBS
|
—
|
|
|
—
|
|
|
34,506
|
|
|
1,199
|
|
||||
Non-Agency RMBS
|
—
|
|
|
—
|
|
|
16,365
|
|
|
42
|
|
||||
U.S. Treasuries
|
197,393
|
|
|
(6,433
|
)
|
|
—
|
|
|
—
|
|
||||
|
$
|
542,469
|
|
|
$
|
(16,219
|
)
|
|
$
|
404,891
|
|
|
$
|
(5,417
|
)
|
|
Repurchase Agreements
|
|
TBA Dollar Roll Positions
(1)
|
||||||||||||||||
($ in thousands)
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
|
Maximum Balance Outstanding During the Quarter Ended
|
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
||||||||||
June 30, 2018
|
$
|
2,514,984
|
|
|
$
|
2,716,097
|
|
|
$
|
2,844,225
|
|
|
$
|
782,408
|
|
|
$
|
722,005
|
|
March 31, 2018
|
2,613,892
|
|
|
2,645,714
|
|
|
2,716,729
|
|
|
844,941
|
|
|
863,615
|
|
|||||
December 31, 2017
|
2,565,902
|
|
|
2,557,573
|
|
|
2,677,894
|
|
|
829,425
|
|
|
928,329
|
|
|||||
September 30, 2017
|
2,519,230
|
|
|
2,616,250
|
|
|
2,801,418
|
|
|
683,813
|
|
|
745,270
|
|
|||||
June 30, 2017
|
2,540,759
|
|
|
2,753,019
|
|
|
2,826,005
|
|
|
416,312
|
|
|
305,720
|
|
(1)
|
Balance outstanding as of quarter end and average balance outstanding for the quarter ended includes TBA dollar roll positions as reported at cost (as if settled). Does not include short TBA positions used to hedge interest rate risk exposure from fixed-rate Agency RMBS in applicable periods.
|
|
June 30, 2018
|
|
March 31, 2018
|
|
December 31, 2017
|
|
September 30, 2017
|
|
June 30, 2017
|
|||||
Agency CMBS and RMBS
|
4.9
|
%
|
|
4.8
|
%
|
|
4.9
|
%
|
|
5.0
|
%
|
|
5.0
|
%
|
Non-Agency CMBS and RMBS
|
—
|
%
|
|
—
|
%
|
|
15.0
|
%
|
|
15.0
|
%
|
|
18.0
|
%
|
CMBS IO
|
13.3
|
%
|
|
13.7
|
%
|
|
14.6
|
%
|
|
15.0
|
%
|
|
15.0
|
%
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||
($ in thousands)
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
||||||||
North America
|
$
|
1,789,056
|
|
|
$
|
1,939,065
|
|
|
$
|
1,551,758
|
|
|
$
|
1,700,582
|
|
Asia
|
412,393
|
|
|
435,215
|
|
|
489,376
|
|
|
515,593
|
|
||||
Europe
|
313,535
|
|
|
328,936
|
|
|
524,768
|
|
|
548,924
|
|
||||
|
$
|
2,514,984
|
|
|
$
|
2,703,216
|
|
|
$
|
2,565,902
|
|
|
$
|
2,765,099
|
|
($ in thousands)
|
|
Payments due by period
|
||||||||||||||||||
Contractual Obligations:
|
|
Total
|
|
< 1 year
|
|
1-3 years
|
|
3-5 years
|
|
> 5 years
|
||||||||||
Repurchase agreements
(1)
|
|
$
|
2,570,587
|
|
|
$
|
2,570,587
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-recourse collateralized financing
(2)
|
|
4,451
|
|
|
1,045
|
|
|
1,891
|
|
|
1,024
|
|
|
491
|
|
|||||
Operating lease obligations
|
|
382
|
|
|
107
|
|
|
275
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
2,575,420
|
|
|
$
|
2,571,739
|
|
|
$
|
2,166
|
|
|
$
|
1,024
|
|
|
$
|
491
|
|
•
|
Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations, and our views on the future performance of MBS and other investments;
|
•
|
Our views on conditions in the investment, credit, and derivatives markets;
|
•
|
Our views on the effect of actual or proposed actions of the U.S. Federal Reserve, the FOMC, or other central banks with respect to monetary policy (including the targeted Federal Funds Rate), and the potential impact of these actions on interest rates, inflation or unemployment;
|
•
|
The effect of regulatory initiatives of the Federal Reserve (including the FOMC), other financial regulators, and other central banks;
|
•
|
Our financing strategy including our target leverage ratios, our use of TBA dollar roll transactions, and anticipated trends in financing costs, and our hedging strategy including changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;
|
•
|
Our investment portfolio composition and target investments;
|
•
|
Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investments;
|
•
|
Our liquidity and ability to access financing, and the anticipated availability and cost of financing;
|
•
|
Our stock repurchase activity and the impact of stock repurchases;
|
•
|
Our use of and restrictions on using our tax NOL carryforward;
|
•
|
The status of pending litigation;
|
•
|
The competitive environment in the future, including competition for investments and the availability of financing;
|
•
|
Estimates of future interest expenses, including related to the Company’s repurchase agreements and derivative instruments;
|
•
|
The status and effect of legislative reforms and regulatory rule-making or review processes, and the status of reform efforts and other business developments in the repurchase agreement financing market;
|
•
|
Market, industry and economic trends, and how these trends and related economic data may impact the behavior of market participants and financial regulators; and
|
•
|
Market interest rates and market spreads.
|
•
|
the risks and uncertainties referenced in this
Quarterly
Report on Form
10-Q
, particularly those set forth under and incorporated by reference into Part II, Item 1A, “Risk Factors”;
|
•
|
our ability to find suitable reinvestment opportunities;
|
•
|
changes in domestic economic conditions;
|
•
|
changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;
|
•
|
our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;
|
•
|
the impact on markets and asset prices from the Federal Reserve’s balance sheet normalization process through the reduction in its holdings of Agency RMBS and U.S. Treasuries;
|
•
|
actual or anticipated changes in Federal Reserve monetary policy or the monetary policy of other central banks;
|
•
|
adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies including in particular China, Japan, the European Union, and the United Kingdom;
|
•
|
uncertainty concerning the long-term fiscal health and stability of the United States;
|
•
|
the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;
|
•
|
the cost and availability of new equity capital;
|
•
|
changes in our use of leverage;
|
•
|
changes to our investment strategy, operating policies, dividend policy or asset allocations;
|
•
|
the quality of performance of third-party servicer providers of our loans and loans underlying our securities;
|
•
|
the level of defaults by borrowers on loans we have securitized;
|
•
|
changes in our industry;
|
•
|
increased competition;
|
•
|
changes in government regulations affecting our business;
|
•
|
changes or volatility in the repurchase agreement financing markets and other credit markets;
|
•
|
changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;
|
•
|
uncertainty regarding continued government support of the U.S. financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including the resolution of the conservatorship of Fannie Mae and Freddie Mac;
|
•
|
the composition of the Board of Governors of the Federal Reserve System;
|
•
|
ownership shifts under Section 382 that further limit the use of our tax NOL carryforward;
|
•
|
systems failures or cybersecurity incidents; and
|
•
|
exposure to current and future claims and litigation.
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||||||
|
|
Percentage Change in
|
|
Percentage Change in
|
||||||||||||||
Parallel Shift in Interest Rates
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Net Interest Income and Net Periodic Interest Costs
(2)
|
||||||
+100
|
|
(1.5
|
)%
|
|
(8.1
|
)%
|
|
1.6
|
%
|
|
(1.7
|
)%
|
|
(10.0
|
)%
|
|
(8.1
|
)%
|
+50
|
|
(0.7
|
)%
|
|
(3.6
|
)%
|
|
1.1
|
%
|
|
(0.7
|
)%
|
|
(4.0
|
)%
|
|
(3.2
|
)%
|
-50
|
|
0.5
|
%
|
|
2.8
|
%
|
|
(2.7
|
)%
|
|
0.3
|
%
|
|
1.8
|
%
|
|
0.7
|
%
|
-100
|
|
0.6
|
%
|
|
3.2
|
%
|
|
(7.4
|
)%
|
|
0.3
|
%
|
|
1.6
|
%
|
|
2.3
|
%
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
(2)
|
Includes changes in net interest income as well as net periodic interest costs on our interest rate swaps recorded in “gain (loss) on derivatives instruments, net”. TBA drop income is not included in the sensitivity analysis for net interest income and net periodic interest costs.
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||||||||
Basis Point Change in
|
|
Percentage Change in
|
||||||||||||
2-year UST
|
|
10-year UST
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
|
Market Value of Investments
(1)
|
|
Shareholders’ Equity
|
||||
+25
|
|
+50
|
|
(0.5
|
)%
|
|
(2.7
|
)%
|
|
(0.5
|
)%
|
|
(3.0
|
)%
|
+25
|
|
+0
|
|
(0.2
|
)%
|
|
(1.0
|
)%
|
|
(0.2
|
)%
|
|
(0.9
|
)%
|
+50
|
|
+25
|
|
(0.5
|
)%
|
|
(2.7
|
)%
|
|
(0.5
|
)%
|
|
(2.8
|
)%
|
+50
|
|
+100
|
|
(1.2
|
)%
|
|
(6.5
|
)%
|
|
(1.3
|
)%
|
|
(7.7
|
)%
|
-10
|
|
-50
|
|
0.3
|
%
|
|
1.4
|
%
|
|
0.1
|
%
|
|
0.8
|
%
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
Basis Point Change in Market Spreads
|
|
Percentage Change in Projected
Market Value of Investments
|
||||
|
|
June 30, 2018
|
|
December 31, 2017
|
||
+50
|
|
(3.5
|
)%
|
|
(3.1
|
)%
|
+25
|
|
(1.8
|
)%
|
|
(1.1
|
)%
|
-25
|
|
1.8
|
%
|
|
1.6
|
%
|
-50
|
|
3.7
|
%
|
|
3.2
|
%
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
PART II.
|
OTHER INFORMATION
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
Exhibit No.
|
Description
|
3.1
|
|
3.2
|
|
10.35
|
|
10.36
|
|
10.36.1
|
|
12.1
|
|
31.1
|
|
31.2
|
|
32.1
|
|
101
|
The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended June 30, 2018, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Statement of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Consolidated Financial Statements.
|
|
|
DYNEX CAPITAL, INC.
|
|
|
|
|
|
|
Date:
|
August 7, 2018
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Chief Executive Officer, President,
|
|
|
Co-Chief Investment Officer, and Director
|
|
|
(Principal Executive Officer)
|
|
|
|
Date:
|
August 7, 2018
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Executive Vice President, Chief Financial Officer and Chief Operating Officer
|
|
|
(Principal Financial Officer)
|
|
Six Months Ended
|
|
Year Ended December 31,
|
||||||||||||||||||||
($ in thousands, except ratios)
|
June 30, 2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||||
Fixed charges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest expense
|
$
|
25,770
|
|
|
$
|
36,178
|
|
|
$
|
25,231
|
|
|
$
|
22,605
|
|
|
$
|
25,915
|
|
|
$
|
39,028
|
|
Preferred dividend requirements
|
5,882
|
|
|
10,794
|
|
|
9,185
|
|
|
9,176
|
|
|
9,176
|
|
|
7,902
|
|
||||||
Total
|
$
|
31,652
|
|
|
$
|
46,972
|
|
|
$
|
34,416
|
|
|
$
|
31,781
|
|
|
$
|
35,091
|
|
|
$
|
46,930
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Earnings:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Income from continuing operations
|
$
|
59,959
|
|
|
$
|
33,893
|
|
|
$
|
43,099
|
|
|
$
|
16,544
|
|
|
$
|
27,806
|
|
|
$
|
68,069
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Distributed income of equity method investee
|
—
|
|
|
—
|
|
|
1,316
|
|
|
—
|
|
|
—
|
|
|
721
|
|
||||||
Fixed charges, excluding preferred dividend requirements
|
25,770
|
|
|
36,178
|
|
|
25,231
|
|
|
22,605
|
|
|
25,915
|
|
|
39,028
|
|
||||||
Less: Equity in income of equity investee
|
—
|
|
|
—
|
|
|
(481
|
)
|
|
(835
|
)
|
|
—
|
|
|
(721
|
)
|
||||||
Total
|
$
|
85,729
|
|
|
$
|
70,071
|
|
|
$
|
69,165
|
|
|
$
|
38,314
|
|
|
$
|
53,721
|
|
|
$
|
107,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Ratio of earnings to fixed charges
|
3.33x
|
|
1.94x
|
|
2.74x
|
|
1.69x
|
|
2.07x
|
|
2.74x
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Ratio of earnings to fixed charges and preferred stock dividends
|
2.71x
|
|
1.49x
|
|
2.01x
|
|
1.21x
|
|
1.53x
|
|
2.28x
|
1.
|
I have reviewed this
Quarterly
Report on Form
10-Q
of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
August 7, 2018
|
|
|
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
1.
|
I have reviewed this
Quarterly
Report on Form
10-Q
of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
August 7, 2018
|
|
|
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
August 7, 2018
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
|
|
|
|
|
|
Date:
|
August 7, 2018
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|